Predicting the risk of bacteremia in children with fever and neutropenia

被引:0
|
作者
Rackoff, WR [1 ]
Gonin, R [1 ]
Robinson, C [1 ]
Kreissman, SG [1 ]
Breitfeld, PP [1 ]
机构
[1] INDIANA UNIV,SCH MED,DEPT MED,DIV BIOSTAT,INDIANAPOLIS,IN 46202
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: We sought to identify factors assessable at the time of admission for fever and neutropenia that predict bacteremia in children with cancer. Patients and Methods: One hundred fifteen consecutive episodes of fever and absolute neutrophil count (ANC) less than 500/mu L in 72 children with cancer were studied prospectively to determine the risk of bacteremia using data assessable at the time of presentation. After exploratory analysis identified admission temperature and absolute monocyte count (AMoC) as the strongest predictive factors, recursive partitioning wets used to determine cutpoints for these variables that resulted in discrimination between episodes associated with a lower or higher risk of bacteremia. Results: There were 24 episodes of bacteremia (21% of episodes), Episodes were grouped using the cutpoints for AMoC and temperature: 17% were classified as low risk for bacteremia (AMoC greater than or equal to 100/mu L), 65% as intermediate risk (AMoC < 100/mu L and temperature < 39.0 degrees C), and 18% as high risk (AMoC < 100/mu L and temperature greater than or equal to 39.0 degrees C). No episodes classified as low risk were associated with bacteremia; 19% of intermediate-risk and 48% of high-risk episodes were associated with bacteremia. The odds ratio of bacteremia for the high-risk versus the intermediate-risk group is 4.4 (95% confidence interval, 1.6 to 12.9). The risk classification was validated using data from 57 different episodes of fever and neutropenia treated in the same hospital. Conclusion: Three levels of risk for bacteremia are defined the AMoC and temperature at the time of admission for fever and neutropenia. Trials now should be conducted to test whether these factors may be used to assign some children to less intensive or outpatient antibiotic therapy at the time of presentation with fever and neutropenia. (C) 1996 by American Society of Clinical Oncology.
引用
收藏
页码:919 / 924
页数:6
相关论文
共 50 条
  • [31] OUTCOMES OF IMMUNOCOMPETENT CHILDREN PRESENTING WITH FEVER AND NEUTROPENIA
    Wittmann, Osnat
    Rimon, Ayelet
    Scolnik, Dennis
    Glatstein, Miguel
    JOURNAL OF EMERGENCY MEDICINE, 2018, 54 (03): : 315 - 319
  • [32] Predicting the risk of severe infection in children with chemotherapy-induced febrile neutropenia
    Dubos, Francois
    Delebarre, Mathilde
    Martinot, Alain
    CURRENT OPINION IN HEMATOLOGY, 2012, 19 (01) : 39 - 43
  • [33] Febrile Neutropenia Syndromes in Children: Risk Factors and Outcomes of Primary, Prolonged, and Recurrent Fever
    Alali, Muayad
    David, Michael Z.
    Ham, Sandra A.
    Danziger-Isakov, Lara
    Pisano, Jennifer
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2021, 43 (07) : E962 - E971
  • [34] PREDICTING THE RISK OF ADVERSE EVENTS IN CHILDREN WITH FEBRILE NEUTROPENIA - VALIDATION OF A CLINICAL RISK ASSESSMENT TOOL
    Kruger, M.
    Green, L. L.
    van Zyl, A.
    PEDIATRIC BLOOD & CANCER, 2015, 62 : S382 - S382
  • [35] Efficacy of Inflammatory Cytokines in Detection of Bacteremia in Children with Febrile Neutropenia
    Tahta, N.
    Karapinar, T. Hilkay
    Erol, A.
    Acar, S. Okur
    Vergin, R. C.
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S545 - S546
  • [36] CHARACTERIZATION, COST, AND OUTCOME OF BACTEREMIA IN CHILDREN WITH FEBRILE NEUTROPENIA AT A CHILDREN'S HOSPITAL
    Eldridge, Brenna
    Knackstedt, Elizabeth
    Korgenski, Kent
    Stockmann, Chris
    Schiffman, Joshua
    Blaschke, Anne
    PEDIATRIC BLOOD & CANCER, 2015, 62 : 94 - 94
  • [37] TREATMENT OF CHILDREN AT RISK FOR BACTEREMIA
    SINGER, JI
    JOURNAL OF PEDIATRICS, 1987, 110 (02): : 331 - 331
  • [38] Risk of bacteremia in children with pneumonia
    Shah, SS
    Alpern, ER
    Zwerling, L
    McGowan, KL
    Bell, LM
    PEDIATRIC RESEARCH, 2002, 51 (04) : 280A - 280A
  • [39] Risks factors for bacteremia in oncology patients receiving empiric antibiotic therapy for fever and neutropenia
    Reynolds, JE
    Zimmerman, S
    Chaffee, S
    Larsen, E
    PEDIATRIC RESEARCH, 2002, 51 (04) : 236A - 236A
  • [40] Predicting the Risk of Severe Bacterial Infection in Children With Chemotherapy-Induced Febrile Neutropenia
    Macher, Emilie
    Dubos, Francois
    Garnier, Nathalie
    Delebarre, Mathilde
    De Berranger, Eva
    Thebaud, Estelle
    Mazingue, Francoise
    Leblond, Pierre
    Martinot, Alain
    PEDIATRIC BLOOD & CANCER, 2010, 55 (04) : 662 - 667